Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Usana Health SciencesSTU:USJ +3.78%67 Net Margin % is 2.78% as of Mar. 2026, which is 66% below its 10-year median of 8.21. GuruFocus rates STU:USJ with a GF Score™ of 67/100 and a GF Value™ of €35.51 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,956 Consumer Packaged Goods companies, Usana Health Sciences ranks worse than 68.25% on this metric.
The historical rank and industry rank for Usana Health Sciences's Net Margin % or its related term are showing as below:
STU:USJ'
s Net Margin % Range Over the Past 10 Years
Min: 0.9 Med: 8.21 Max: 10.99
Current: 0.9
STU:USJ's Net Margin % is ranked worse than 68.25% of 1956
companies
in the Consumer Packaged Goods industry
Industry Median: 3.51
vs STU:USJ: 0.90
Usana Health Sciences (STU:USJ) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Usana Health Sciences Net Margin % Related Terms
Usana Health Sciences Net Margin % Historical Data
* Premium members only.
The historical data trend for Usana Health Sciences's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:USJ vs NATR, ENHA, BYND: Net Margin % Comparison
For the Packaged Foods subindustry, Usana Health Sciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Usana Health Sciences Net Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's Net Margin % distribution charts can be found below:
* The bar in red indicates where Usana Health Sciences's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Usana Health Sciences (STU:USJ) has a Net Margin % of 2.78% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Usana Health Sciences and its competitors. This is 66% below median its historical median of 8.21. Over the past decade, Usana Health Sciences' Net Margin % has ranged from 0.90 to 10.99. According to the industry distribution chart, Usana Health Sciences ranks #1335 out of 1956 companies in the Consumer Packaged Goods industry, placing it in the top 68.3%.
Is Usana Health Sciences' Net Margin % too high?
Usana Health Sciences' current Net Margin % of 2.78% is 66% below median its 10-year median of 8.21. Over the past 10 years, this metric has ranged from a low of 0.90 to a high of 10.99. The Consumer Packaged Goods industry median Net Margin % is 3.51. Usana Health Sciences' value of 2.78% is 20.8% below this industry median. Based on the distribution chart, Usana Health Sciences ranks #1335 out of 1956 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Usana Health Sciences has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Usana Health Sciences' Net Margin % compare to NATR and ENHA?
According to the Consumer Packaged Goods industry distribution chart, Usana Health Sciences ranks #1335 out of 1956 companies for Net Margin %. This places Usana Health Sciences in the lower half of its industry. The industry median Net Margin % is 3.51. Usana Health Sciences' value of 2.78% is 20.8% below this benchmark. Historically, Usana Health Sciences' own Net Margin % has ranged from 0.90 to 10.99 over the past decade. While the company's 10-year median is 8.21 vs. the industry median of 3.51, Usana Health Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Consumer Packaged Goods company?
The median Net Margin % among Consumer Packaged Goods companies is 3.51, based on 1,956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Usana Health Sciences's current Net Margin % of 2.78% is 20.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Usana Health Sciences and its competitors. For the Consumer Packaged Goods industry, the median Net Margin % is 3.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Usana Health Sciences's current Net Margin % is 2.78%, which is 66% below median its own 10-year median of 8.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Usana Health Sciences stock overvalued right now?
Based on GuruFocus' analysis, Usana Health Sciences (STU:USJ) is currently considered Possible Value Trap. The stock's GF Value™ is €35.51, compared to a current price of €19.20 — trading 45.9% below its estimated fair value. The current Net Margin % is 2.78%, which is 66% below median its 10-year median of 8.21 and 20.8% below the Consumer Packaged Goods industry median of 3.51. Usana Health Sciences' overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Usana Health Sciences (STU:USJ), the current Net Margin % is 2.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Usana Health Sciences (STU:USJ) Overvalued in 2026?
Based on GuruFocus' analysis, Usana Health Sciences stock appears to be undervalued.
The current stock price of €19.20 is trading 45.9% below its estimated GF Value™ of €35.51.
GuruFocus considers Usana Health Sciences to be Possible Value Trap.
Key valuation signals for STU:USJ:
Net Margin %: 2.78% (66% below median its 10-year median of 8.21)
GF Value™: €35.51 vs. price of €19.20 (45.9% below fair value)
Industry Position: 20.8% below the Consumer Packaged Goods median (#1335 of 1956)
No single metric tells the full story. See the STU:USJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
67GF Score
Get the complete analysis for STU:USJ
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:USJ has been successfully added to your 
